| ISIN | LI0012960956 |
|---|---|
| Valor Number | 1296095 |
| Bloomberg Global ID | |
| Fund Name | Aquila International Fund - Corby Swiss Equity (CHF) |
| Fund Provider |
Aquila AG
Zürich, Switzerland Phone: +41 58 680 60 00 Web: www.aquila.ch |
| Fund Provider | Aquila AG |
| Representative in Switzerland |
LLB Swiss Investment AG Zürich |
| Distributor(s) | LB (Swiss) Investment AG |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Liechtenstein |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 2,841.58 CHF | 27.10.2025 |
|---|---|---|
| Previous Price * | 2,845.44 CHF | 24.10.2025 |
| 52 Week High * | 2,878.50 CHF | 19.08.2025 |
| 52 Week Low * | 2,377.05 CHF | 09.04.2025 |
| NAV * | 2,841.58 CHF | 27.10.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 68,426,356 | |
| Unit/Share Assets *** | 64,525,961 | |
| Trading Information SIX | ||
| YTD Performance | +8.40% |
31.12.2024 - 27.10.2025
31.12.2024 27.10.2025 |
|---|---|---|
| 1 month | +2.66% |
29.09.2025 - 27.10.2025
29.09.2025 27.10.2025 |
| 3 months | -0.27% |
28.07.2025 - 27.10.2025
28.07.2025 27.10.2025 |
| 6 months | +6.79% |
28.04.2025 - 27.10.2025
28.04.2025 27.10.2025 |
| 1 year | +4.54% |
28.10.2024 - 27.10.2025
28.10.2024 27.10.2025 |
| 2 years | +34.26% |
27.10.2023 - 27.10.2025
27.10.2023 27.10.2025 |
| 3 years | +34.71% |
27.10.2022 - 27.10.2025
27.10.2022 27.10.2025 |
| 5 years | +40.66% |
27.10.2020 - 27.10.2025
27.10.2020 27.10.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 6.18% | |
|---|---|---|
| UBS Group AG Registered Shares | 5.76% | |
| Nestle SA | 5.35% | |
| Roche Holding AG | 5.19% | |
| Accelleron Industries AG Ordinary Shares | 5.08% | |
| ABB Ltd | 5.05% | |
| Lonza Group Ltd | 5.04% | |
| Compagnie Financiere Richemont SA Class A | 4.25% | |
| Swissquote Group Holding SA | 4.06% | |
| Swiss Re AG | 3.70% | |
| Last data update | 31.08.2025 | |
| TER *** | 1.83% |
|---|---|
| TER date *** | 31.12.2024 |
| Performance Fee *** | 10.00% |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | 1.80% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |